Deregulated MIR335 that targets MAPK1 is implicated in poor outcome of paediatric acute lymphoblastic leukaemia. - Wikidata - awgldk - TriplyDB

Deregulated MIR335 that targets MAPK1 is implicated in poor outcome of paediatric acute lymphoblastic leukaemia.

Deregulated MIR335 that targets MAPK1 is implicated in poor outcome of paediatric acute lymphoblastic leukaemia.

http://www.wikidata.org/entity/Q39120062

about

Clinical significance of microRNAs in chronic and acute human leukemia MicroRNAs as tools to predict glucocorticoid response in inflammatory bowel diseases MEK Inhibition Sensitizes Precursor B-Cell Acute Lymphoblastic Leukemia (B-ALL) Cells to Dexamethasone through Modulation of mTOR Activity and Stimulation of Autophagy MicroRNAome genome: a treasure for cancer diagnosis and therapy.The Oncogenic Response to MiR-335 Is Associated with Cell Surface Expression of Membrane-Type 1 Matrix Metalloproteinase (MT1-MMP) Activity.Pharmacogenetic considerations for acute lymphoblastic leukemia therapies.Ras/Raf/MEK/ERK Pathway Activation in Childhood Acute Lymphoblastic Leukemia and Its Therapeutic Targeting Pharmacogenetics of childhood acute lymphoblastic leukemia.Genetic variation in the glucocorticoid pathway involved in interindividual differences in the glucocorticoid treatment.MicroRNAs as prognostic biomarker and relapse indicator in leukemia.A signal-based method for finding driver modules of breast cancer metastasis to the lung.MiR-143 inhibits endometrial cancer cell proliferation and metastasis by targeting MAPK1.MiRNA Dysregulation in Childhood Hematological Cancer

P2860

Q26749533-EB2CED74-ED6F-4676-B654-BFB57F8B1E1F Q27011618-8A942735-6EE4-44C6-A341-BE1726E3FDB8 Q28552218-00329673-C1B7-4E70-9352-C30A8A33D4A4 Q35704188-F3CD1E48-4517-40F1-8010-7B9AD514CBBC Q35708443-32C3A1DE-DEAE-4B40-87C4-1E04D6E5300C Q38199738-CCFCE0F1-03F8-443B-A733-CD79B3B62D38 Q38227885-29770CD5-082A-45E9-B793-D41EC581469A Q38243175-52414756-D1B9-45AB-86F1-E5816FA7A195 Q39098740-0F1B8C9C-5E87-4F45-B817-68D6FF0883C9 Q39167466-D2EE311E-6B0B-4E01-BAEF-68C99F92A5C1 Q41564767-5D2CC0F9-CD8E-4922-8A7C-5B2231892A4C Q46332987-D1220611-E137-4535-A527-BEB9CF95F244 Q58753107-7F1E757F-7B4C-461D-B8F9-FF4CAB13BB63

P2860

Deregulated MIR335 that targets MAPK1 is implicated in poor outcome of paediatric acute lymphoblastic leukaemia.

http://www.wikidata.org/entity/Q39120062

description

2013 nî lūn-bûn

@nan

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

2013年论文

@zh

2013年论文

@zh-cn

name

Deregulated MIR335 that target ...... acute lymphoblastic leukaemia.

@en

Deregulated MIR335 that target ...... acute lymphoblastic leukaemia.

@nl

type

label

Deregulated MIR335 that target ...... acute lymphoblastic leukaemia.

@en

Deregulated MIR335 that target ...... acute lymphoblastic leukaemia.

@nl

prefLabel

Deregulated MIR335 that target ...... acute lymphoblastic leukaemia.

@en

Deregulated MIR335 that target ...... acute lymphoblastic leukaemia.

@nl

P1433

Q39120062-DE4E844F-8EE4-4B08-93AF-60D4822347CD

P1476

Q39120062-541F4C8C-3077-4C70-9983-9BE94C8EF9E0

P2093

Q39120062-224FF4E4-B6E1-4D49-AF6C-D5343F2EC166

Q39120062-2EB84623-475B-4C5A-9CCD-8BFE44B7146A

Q39120062-4A479A82-7073-4C95-9039-D109F9C6E3CA

Q39120062-4CE91329-AFE2-4B1A-85AF-6CC583759774

Q39120062-5912CBB8-2C6C-4186-8204-D1ED36E7B232

Q39120062-606BCE32-4BDD-484A-A979-37C53CBD5F59

Q39120062-827FACD4-CB1C-40E8-A191-34E6211F022A

Q39120062-97CB57BC-26CB-4A25-82BC-1CDDDA97728F

Q39120062-B6983D07-13D7-4493-9088-50618C486DA8

Q39120062-D1FD1A39-195B-473B-91F5-8DF1AAB61955

P2860

Q39120062-02E86824-1857-4A9F-BA9B-B0B4E421283E

Q39120062-03B3C4A0-182B-4A08-9F0B-714B3A9598E4

Q39120062-0A3CBB16-4E6F-444F-B5F3-2E34D0FE5F00

Q39120062-0D65684C-0242-46C4-A951-01E85A8E7FE5

Q39120062-0FDCC308-F1B3-4279-821A-E2F15B3B0B11

Q39120062-2D272070-B30E-4082-9B01-25077F58E864

Q39120062-2D2B9E33-E668-442A-B29B-6A2187A68754

Q39120062-37191DF7-040E-4791-A12F-ECD551CB2CC6

Q39120062-3C036A87-4AD4-4B2D-9897-BC0DCB1EEF28

Q39120062-5525D643-444C-42ED-97BC-568C651B307A

P304

Q39120062-93714C34-87B1-4F82-B6DB-8378AD0D2206

P31

Q39120062-51D16F00-8E24-404C-A310-80BDD31B36E7

P356

Q39120062-A18AA1D0-2BEA-46A9-B2D7-6A1F4C6151B2

P407

Q39120062-07E29505-CFE4-4677-A55D-C37B53321748

P433

Q39120062-09F11CA0-6399-462C-BF75-EAC4D10829D3

P478

Q39120062-F4D9F076-E792-476D-8FC5-F0C46AB3CC5B

P50

Q39120062-4D62E3F5-D8EF-4947-9934-4C6CC27A76DA

Q39120062-62077A5D-8862-4E33-815F-E8892E1896BF

Q39120062-B0AEEEB2-08F9-4920-AE74-62035792A641

P577

Q39120062-EA7666B1-464D-4529-A847-80132B02465E

P698

Q39120062-B0BC2C1C-4200-44C7-98EE-A5B8C4A026C6

P921

Q39120062-13745919-A2FE-4E20-93AC-6D17AC7BA1C6

P356

P1433

British Journal of Haematology

P1476

Deregulated MIR335 that target ...... acute lymphoblastic leukaemia

@en

P2093

Allen E J Yeoh

http://www.w3.org/2001/XMLSchema#string

Chonglei Bi

http://www.w3.org/2001/XMLSchema#string

Gaofeng Huang

http://www.w3.org/2001/XMLSchema#string

Grace S Koh

http://www.w3.org/2001/XMLSchema#string

Hany Ariffin

http://www.w3.org/2001/XMLSchema#string

Jim L-S Tay

http://www.w3.org/2001/XMLSchema#string

Joy Tan

http://www.w3.org/2001/XMLSchema#string

Junli Yan

http://www.w3.org/2001/XMLSchema#string

Shirley K Y Kham

http://www.w3.org/2001/XMLSchema#string

Tae-Hoon Chung

http://www.w3.org/2001/XMLSchema#string

P2860

Clinical outcome prediction by microRNAs in human cancer: a systematic review

miR-128b is a potent glucocorticoid sensitizer in MLL-AF4 acute lymphocytic leukemia cells and exerts cooperative effects with miR-221

Roles of the Raf/MEK/ERK pathway in cell growth, malignant transformation and drug resistance

Mammalian microRNAs predominantly act to decrease target mRNA levels

MicroRNAs: genomics, biogenesis, mechanism, and function

Endogenous human microRNAs that suppress breast cancer metastasis

MicroRNA patterns associated with clinical prognostic parameters and CNS relapse prediction in pediatric acute leukemia.

Mer receptor tyrosine kinase is a novel therapeutic target in pediatric B-cell acute lymphoblastic leukemia

A set of miRNAs that involve in the pathways of drug resistance and leukemic stem-cell differentiation is associated with the risk of relapse and glucocorticoid response in childhood ALL

Identification of hsa-miR-335 as a prognostic signature in gastric cancer.

P304

93-103

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/BJH.12489

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

163

http://www.w3.org/2001/XMLSchema#string

P50

P577

2013-07-25T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

23888996

http://www.w3.org/2001/XMLSchema#string

P921